Abstracts - faqs.org

Abstracts

Health

Search abstracts:
Abstracts » Health

Interferon-gamma in the management of infectious diseases

Article Abstract:

Interferon-gamma may be effective in treating chronic granulomatous disease and certain bacterial and parasitic diseases. Interferon-gamma is one of many natural proteins produced by the body in reaction to infection. Patients with chronic granulomatous disease have an immune system deficiency allowing frequent infections to occur and fibrous tissue masses to form. Researchers reviewed current hypotheses on interferon-gamma's biological pathway of action and the diseases for which this natural protein may be effective. Immune response improved in thirty-four patients with chronic granulomatous disease treated with interferon-gamma. Given together with antibiotics, interferon-gamma has also been effective in treating two bacterial infections, leprosy and M. avium complex infections. Interferon-gamma treatment has also been effective in treating two parasitic infections, toxoplasmosis and leishmania.

Author: Gallin, John I., Holland, Steven M., Nutman, Thomas B., Farber, Joshua M.
Publisher: American College of Physicians
Publication Name: Annals of Internal Medicine
Subject: Health
ISSN: 0003-4819
Year: 1995
Health aspects, Interferon gamma, Opportunistic infections, Toxoplasmosis, Leishmaniasis, Chronic granulomatous disease

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Effects of naloxone infusions in patients with the pruritus of cholestasis: a double-blind, randomized, controlled trial

Article Abstract:

Treatment with naloxone may help to relieve the itching symptoms of cholestasis. Cholestasis is an interruption in the flow of digestive fluids from or within the liver. Researchers compared the effect of naloxone with a placebo in 29 patients with itching symptoms associated with cholestasis. Patients randomly received either intravenous naloxone or placebo in 24-hour increments over a 4-day period. Patients rated their perception of itch on a scale from 0 to 10 every 4 waking hours. Researchers also electronically monitored the scratching movements of the patients. The patients reported a lower perception of itch with naloxone as compared to placebo. Scratching activity also declined with naloxone treatment as compared to placebo.

Author: Alling, David W., Jones, E. Anthony, Turner, Maria L., Yurdaydin, Cihan, Bergasa, Nora Valeria, Talbot, Thomas L., Swain, Mark G., Schmitt, Joseph M., Walker, Elijah C.
Publisher: American College of Physicians
Publication Name: Annals of Internal Medicine
Subject: Health
ISSN: 0003-4819
Year: 1995
Evaluation, Cholestasis, Naloxone, Pruritus, Itching

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA



Subjects list: Complications and side effects, Drug therapy
Similar abstracts:
  • Abstracts: The influence of birth weight on labor in nulliparas. Prophylactic insulin in the management of gestational diabetes
  • Abstracts: Ganglioside GM3:GD3 ratio as an index for the management of melanoma. A phase I-II study of dacarbazine in combination with outpatient interleukin-2 in metastatic malignant melanoma
  • Abstracts: Reported practices of pediatric residents in the management of attention-deficit hyperactivity disorder. part 2
  • Abstracts: Large-volume paracentesis in treatment of ascites. Antibiotic-induced D-lactic acidosis. Increased osmolal gap in alcoholic ketoacidosis and lactic acidosis
  • Abstracts: Interrelations between carbohydrates, lipids and the hemostatic system in relation to the risk of thrombotic and cardiovascular disease
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.